- TOP
- Company Information
- Vision/History

Vision/Company History
"Composing the Future"
for all customers
1952s
Period Focused on Contract Manufacturing
Prior to 1985, approximately 50% of our business was in contract manufacturing and we were a relatively small company with an annual turnover of 300 million yen. Quality management was our top priority and we were not yet involved in new product development.
Business/Operations | Products/Technologies |
---|---|
![]() |
|
Business/Operations | Products/Technologies |
---|---|
![]() |
Business/Operations | Products/Technologies |
---|---|
![]() |
Business/Operations | Products/Technologies |
---|---|
|
Business/Operations | Products/Technologies |
---|---|
|
1985s
Growing Demand for Esters, Plant Relocation and Korean market approach
With the easing of regulations for cosmetic ingredients and technologies and for esters production methods, we aimed at breaking away from contract manufacturing and developing our own products such as higher alcohol flakes. We relocated our plant to Taiei-machi (currently Narita City) with a new esterification unit, allowing us to increase our production capacity by five times, and launched our core products “ISOSTEARIC ACID”.
We also developed a full-fledged approach to South Korea, a country to which we had exported only small amounts at that time, by focusing our marketing strategy on our high quality and competitive prices. During this period, we also started investigating raw material sources from overseas.
Business/Operations | Products/Technologies |
---|---|
|
Business/Operations | Products/Technologies |
---|---|
|
Business/Operations | Products/Technologies |
---|---|
![]() |
Business/Operations | Products/Technologies |
---|---|
|
![]() |
Business/Operations | Products/Technologies |
---|---|
|
|
Business/Operations | Products/Technologies |
---|---|
|
Business/Operations | Products/Technologies |
---|---|
|
Business/Operations | Products/Technologies |
---|---|
|
Business/Operations | Products/Technologies |
---|---|
![]() ![]() |
Business/Operations | Products/Technologies |
---|---|
![]() |
2001s
New product development, global expansion and product differentiation by quantifying functionality
From 2000, we used our experience in penetrating the Korean market, substituted ingredients from animal or petroleum origins with plant-based materials and developed functional ingredients such as “HAILUCENT ISDA" and "RISOCAST DA" to target the European and American markets. In 2008, we established our affiliate company ESTENITY in Lyon, France to comply with "REACH", the chemical regulation enforced in the European Union since 2007.
In 2010, we introduced numerical values in addition to our sensory evaluations of lipsticks and lip glosses to quantify the feel of our products on the skin and make possible suggestions based on objective data.
Business/Operations | Products/Technologies |
---|---|
|
Business/Operations | Products/Technologies |
---|---|
|
![]() ![]() |
Business/Operations | Products/Technologies |
---|---|
![]() |
Business/Operations | Products/Technologies |
---|---|
|
|
Business/Operations | Products/Technologies |
---|---|
|
![]() ![]() |
Business/Operations | Products/Technologies |
---|---|
![]() ![]() |
Business/Operations | Products/Technologies |
---|---|
![]() |
Business/Operations | Products/Technologies |
---|---|
|
|
Business/Operations | Products/Technologies |
---|---|
|
![]() |
Business/Operations | Products/Technologies |
---|---|
|
Business/Operations | Products/Technologies |
---|---|
|
![]() |
Business/Operations | Products/Technologies |
---|---|
|
Business/Operations | Products/Technologies |
---|---|
|
![]() |
2016s
New Plant and R&D Center Established and the New Challenge of Entering the Pharmaceutical Market
Since 2011, we had been focusing on new product development based on skin science and also technical application to haircare formulations.
Following a long preparatory period, construction of the Second Plant and R&D Center was completed in 2016. We embarked on a new chapter to enter fully into the pharmaceutical market.
Business/Operations | Products/Technologies |
---|---|
![]() |
Business/Operations | Products/Technologies |
---|---|
|
![]() |
Business/Operations | Products/Technologies |
---|---|
|
Business/Operations | Products/Technologies |
---|---|
![]() ![]()
|
![]() |
Business/Operations | Products/Technologies |
---|---|
![]() |
Business/Operations | Products/Technologies |
---|---|
|